Issues and Challenges EPC Report 4 Cover pages.indd 53 2/20/2011 8:19:18 PM Contents Chemtech Foreword KPMG Foreword Executive Summary Acronyms Used Methodology Coverage and Scope Setting the Context Value Creation Strategies Key External Drivers and Issues Key Internal Issues End-Use Industry Views EPC Industry in India Action Agenda for Sustained Growth Acknowledgements About Chemtech About KPMG in India 48 51 52 52 2 3 4 4 8 8 10 17 22 29 33 |1 | EPC Industry in India: Issues and Challenges
Words: 19229 - Pages: 77
upon development of CSR in India; study the theoretical concepts expounded by various researchers and study the deployment of current CSR practices in India. This paper examines how India’s top 500 companies view, and conduct their CSR, identifies key CSR practices and maps these against Global Reporting Initiative standards. Design/methodology/approach -It is a cross sectional study which is exploratory in nature. It involved secondary data collection and use of content analysis technique to assess
Words: 7834 - Pages: 32
INDIAN LOGISTICS INDUSTRY May 2012 Index I. II. Executive Summary Market Overview – – – – – – – – Industry Overview Structure of the Industry Five Forces Model Growth Drivers Trends in the Industry Government Initiative Opportunities in the sector Challenges in the sector III. Industry Analysis III. Major Players – Major Companies – Common Stock Comparables IV. Organized Players in Logistics Segment – – – – – Container Rail Business Multimodal Transport Operation Container Freight
Words: 6615 - Pages: 27
A critical analysis of AstraZeneca plc.’s shareholder wealth creation in the five-year period from 2010-15 * Xiaoyu Zhang August 2016 MSC in Accounting and Financial Management Global Pharmaceutical Industry Overview Pharmaceutical industry is closely bound up with people’s living standard, which also correlates general economic and deserves thoroughly research and analysis. Due to favorable demographic trends and significant unmet medical needs, the pharmaceutical industry is
Words: 5872 - Pages: 24
Strategy Template.dot Strategy INDIA INDIA June 28, 2010 BSE-30:17,575 The 100 Billion Dollar Club. We analyze Indian companies and their attributes such as (1) IPR (brand and technology), (2) financial and industrial assets and (3) natural resources that can propel them to US$100 bn market capitalization over a period of time. We also look at global experience to draw conclusions for India; every decade throws up new and interesting names. Finally, we assess operating factors that are
Words: 28995 - Pages: 116
global market research firm Nielsen, which has conducted on our behalf nearly 16,000 face-to-face interviews with consumers across nine key emerging economies – Brazil, China, India, Indonesia, Mexico, Russia, Saudi Arabia, Turkey and South Africa. We have built a unique and accessible multi-year database profiling the fortunes and intentions of these key consumers. The ambition of our series of studies has been to focus on the micro
Words: 21734 - Pages: 87
ALL Friday, September 6, 2013 Rs. 1.50, Pages 8 Vol. 20 No. 249 http://www.bloncampus.com AHMEDABAD G BANGALORE G CHENNAI G COIMBATORE G HUBLI G HYDERABAD G KOCHI G KOLKATA G MADURAI G MALAPPURAM G MANGALORE G MUMBAI G NOIDA G THIRUVANANTHAPURAM G TIRUCHIRAPALLI G VIJAYAWADA G VISAKHAPATNAM ON CAMPUS FAST TRACK Harvard tops list of alma maters of CEOs London, Sept. 5 twitter.com/bloncampus facebook.com/groups/bloncampus bloncampus@thehindu.co.in arvard University of the US
Words: 3131 - Pages: 13
Dabur India Limited | 01 CORPORATE INFORMATION BOARD OF DIRECTORS Dr. Anand Burman Chairman Mr. Amit Burman Vice Chairman Mr. Pradip Burman Director Mr. Mohit Burman Director Mr. P. D. Narang Director Mr. Sunil Duggal Director Mr. R. C. Bhargava Director Mr. P. N. Vijay Director Dr. S. Narayan Director Mr. Albert Wiseman Paterson Director Mr. Analjit Singh Director Dr. Ajay Dua Director GM (FINANCE) & COMPANY SECRETARY AUDITORS Mr. A. K. Jain M/s G. Basu & Co. Chartered Accountants
Words: 80849 - Pages: 324
• TI SI PO C R E AT I N G A C ONTENTS 24 MANAGEMENT DISCUSSION AND ANALYSIS 42 BOARD OF DIRECTORS 45 MANAGEMENT COUNCIL 72 DIRECTORS’ REPORT 2 CHAIRMAN’S LETTER 46 CORPORATE GOVERNANCE 89 IGAAP STANDALONE FINANCIALS 4 KEY HIGHLIGHTS 60 ADDITIONAL SHAREHOLDERS’ INFORMATION 70 FIVE YEARS AT A GLANCE 141 IGAAP CONSOLIDATED FINANCIALS 6 THE DNA OF SUSTAINABILITY 187 EXTRACT OF IFRS CONSOLIDATED FINANCIALS 190 STATEMENT PURSUANT TO SECTION 212 OF THE COMPANIES
Words: 111729 - Pages: 447
9-604-101 REV: JUNE 20, 2006 GARY PISANO LEE FLEMING Vertex Pharmaceuticals: R&D Portfolio Management (A) EEEddduuucccaaatttiiiooonnnaaalll mmmaaattteeerrriiiaaalll sssuuuppppppllliiieeeddd bbbyyy TTThhheee CCCaaassseee CCCeeennntttrrreee CCCooopppyyyrrriiiggghhhttt eeennncccooodddeeeddd AAA777666HHHMMM---JJJUUUJJJ999KKK---PPPJJJMMMNNN999III OOOrrrdddeeerrr rrreeefffeeerrreeennnccceee FFF222555222999888333 I’ve never made a bad
Words: 11207 - Pages: 45
